PEDIATRICS Vol. 75 No. 3 March 1985, pp. 569-574
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frank, L.
Right arrow Articles by Sosenko, I. R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frank, L.
Right arrow Articles by Sosenko, I. R. S.

Dexamethasone Stimulation of Fetal Rat Lung Antioxidant Enzyme Activity in Parallel With Surfactant Stimulation

Lee Frank MD, PhD1, Pamela L. Lewis BS1, and Ilene R. S. Sosenko MD1

1 From the Pulmonary Research Division and Oak Asthma Research and Treatment Facility, University of Miami School of Medicine, Miami

It has recently been determined that fetal lung antioxidant enzyme activity markedly increases late in gestation. A test was made of whether this normal late-in-gestation change in O2-protective enzymes would be responsive to the maturing effect of hormonal (glucocorticoid) treatment. Pregnant rats received 0.2 mg/kg of dexamethasone (or saline) at 48 and 24 hours prior to delivery of their fetuses on gestational days 19, 20, 21, and 22 (newborn). Lung disaturated phosphatidylcholine showed an expected response to prenatal dexamethasone exposure with significant elevations of surfactant lipid at gestational days 20 and 21. A similar effect of prenatal dexamethasone treatment on the lung antioxidant defensive system was found. Superoxide dismutase, catalase, and glutathione peroxidase—enzymes protective against hyperoxia-induced lung injury—showed an accelerated pattern of maturation with significant increases in the dexamethasone-treated fetal lungs compared with control fetal lung enzyme levels at gestational days 20 and 21. The results suggest that prenatal dexamethasone treatment may have dual benefits when used in impending premature deliveries—that is, it may stimulate maturation of both the surfactant system and also the antioxidant enzyme system, and this maturation can help protect the premature newborn's lungs from the toxic complications of hyperoxic therapy that may be required because of immaturity.

Key Words: dexamethasone • surfactant stimulation • oxygen toxicity • fetal lung maturation • antioxidant enzymes

Submitted on February 24, 1984
Accepted on May 17, 1984




This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
H.-S. Kim, J. H. Pak, L. W. Gonzales, S. I. Feinstein, and A. B. Fisher
Regulation of 1-cys Peroxiredoxin Expression in Lung Epithelial Cells
Am. J. Respir. Cell Mol. Biol., August 1, 2002; 27(2): 227 - 233.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Ahlbom, V. Gogvadze, M. Chen, G. Celsi, and S. Ceccatelli
Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death
PNAS, December 8, 2000; (2000) 260501697.
[Abstract] [Full Text]

Home page
 PediatricsHome page
J. P. Shenai, B. G. Mellen, and F. Chytil
Vitamin A Status and Postnatal Dexamethasone Treatment in Bronchopulmonary Dysplasia
Pediatrics, September 1, 2000; 106(3): 547 - 553.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
F. J. Walther, A. H. Jobe, and M. Ikegami
Repetitive prenatal glucocorticoid therapy reduces oxidative stress in the lungs of preterm lambs
J Appl Physiol, July 1, 1998; 85(1): 273 - 278.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
J. Vyas and S. Kotecha
Effects of antenatal and postnatal corticosteroids on the preterm lung
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 1997; 77(2): 147F - 150.
[Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Ahlbom, V. Gogvadze, M. Chen, G. Celsi, and S. Ceccatelli
Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death
PNAS, December 19, 2000; 97(26): 14726 - 14730.
[Abstract] [Full Text] [PDF]